ACCDiS welcomes its new postdocs
Sergio Lavandero, Director of the Center for advanced chronic diseases, It received to the researchers who were awarded the Postdoctoral scholarships for Chilean and foreign competition It offered ACCDiS at the beginning of year.
The selected doctors, Carolina Arrúa, Valeria Garrido and Keila Torres, they visited the offices of ACCDiS, located in the Emeritus Faculty building of the Facultad de Ciencias Químicas y Farmacéuticas of the University of Chile. There, they were able to know in depth the work done in the FONDAP Center and know before beginning his postdoctoral.
New postdocs from ACCDiS
Carolina Arrúa – who will develop its work on lines biology of tumor cells and inflammation and nanomedicine and chemistry science for the diagnosis and therapy of cancer and cardiovascular diseases- It is a degree in biotechnology and Ph.d. in chemical sciences from the Universidad Nacional de Rosario (Argentina) with the theme "design and in-vitro/in vivo Evaluation of polymer micro systems- and nanoparticulate drug".
In both, Valeria Garrido is pharmaceutical chemistry of the Universidad de Valparaíso, Master's degree in pharmacology and PhD (c) in pharmacology from the University of Chile with his thesis "effect of the factor of growth and differentiation 11 (gdf11) in metabolism and communication reticle sarcoplasmic-mitochondria in cardiomyocyte hypertrophic". Garrido will play in metabolic signaling in heart failure and biomarkers research gender differences in heart failure.
On the other hand, Keila Torres holds a degree in biology in the University of the Andes (ULA) and PhD in biological sciences from the Universidad Simón Bolívar (USB) -two Venezuelan higher education institutions- with his thesis "Association study of polymorphism of single nucleotides and gastric cancer in Venezuela". She will play their labors in the lines of research of scenarios epigenomic in gastric cancer and natural history of digestive cancer.
On behalf of ACCDiS we wish our postdocs much success in this new step in his career and invite them to continue working for the prevention, treatment and investigation of chronic diseases.